Last year, infectious diseases topped new sponsored clinical research in Malaysia, reversing the trend since 2012 when oncology comprised the majority of studies, involving novel therapies.
Dr Voon Pei Jye from Sarawak General Hospital notes that there are very limited Malaysian Phase One oncology clinical trials published in international journals from 2011 to 2020.